The DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.
PLASMA-HIGH-DENSITY-LIPOPROTEIN CONCENTRATION AND DEVELOPMENT OF ISCHÆMIC HEART-DISEASE
Abstract
The body cholesterol pool increases with decreasing plasma-high-density-lipoprotein (H.D.L.) but is unrelated to the plasma concentrations of total cholesterol and other lipoproteins. This finding supports existing evidence that H.D.L. facilitates the uptake of cholesterol from peripheral tissues and its transport to the liver for catabolism and excretion. Plasma-H.D.L., is reduced in several conditions associated with an increased risk of future ischaemic heart-disease (I.H.D.), namely hypercholesterolaemia, hypertriglyceridaimia, male sex, obesity, and diabetes mellitus, while subjects with existing clinical I.H.D. have lower levels of H.D.L. than healthy subjects within the same community. It is proposed that a reduction of plasma-H.D.L. concentration may accelerate the development of atherosclerosis, and hence I.H.D., by impairing the clearance of cholesterol from the arterial wall.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“there is an inverse relationship between serum HDL levels and the risk of coronary heart disease49,50.”
From Perspectives and opportunities for nanomedicine in the management of atherosclerosis (2011) · cites this paper as [49]
In the citing paper
“For many decades, a low level of HDL-C has been viewed as a robust and independent CVD risk factor1-4.”
From Is Isolated Low High-Density Lipoprotein Cholesterol a Cardiovascular Disease Risk Factor?: New Insights From the Framingham Offspring Study (2016) · cites this paper as [1]
Citations
Cites
The plasma lecithin:cholesterol acyltransferase reaction
Glomset, J. A. (1968) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)43114-1 · Cited by 2,396
Serum cholesterol, lipoproteins, and the risk of coronary heart disease. The Framingham study.
Kannel, W., Castelli, W., Gordon, T., & McNamara, P. M. (2020) · Annals of Internal Medicine · doi:10.7326/0003-4819-74-1-1 · Cited by 2,160
Fat Transport in Lipoproteins — An Integrated Approach to Mechanisms and Disorders
Fredrickson, D. S., Levy, R. I., & Lees, R. S. (1967) · New England Journal of Medicine · doi:10.1056/nejm196701052760107 · Cited by 1,911
ISCHÆMIC HEART-DISEASE IN RELATION TO FASTING VALUES OF PLASMA TRIGLYCERIDES AND CHOLESTEROL
Carlson, L., & Böttiger, L. E. (1972) · The Lancet · doi:10.1016/s0140-6736(72)90738-6 · Cited by 752
PLASMA LIPID AND LIPOPROTEIN PATTERN IN GREENLANDIC WEST-COAST ESKIMOS
Bang, H. O., Dyerberg, J., & Nielsen, A. B. (1971) · The Lancet · doi:10.1016/s0140-6736(71)91658-8 · Cited by 690
Protein-lipid relationships in human plasma
Barr, D. P., Russ, E. M., & Eder, H. A. (1951) · The American Journal of Medicine · doi:10.1016/0002-9343(51)90183-0 · Cited by 635
RISKS OF ISCHÆMIC HEART-DISEASE IN FAMILIAL HYPERLIPOPROTEINÆMIC STATES
Slack, J. (1969) · The Lancet · doi:10.1016/s0140-6736(69)90930-1 · Cited by 625
PLASMA LIPID AND LIPOPROTEIN PATTERN IN GREENLANDIC WEST-COAST ESKIMOS
Bang, H. O., Dyerberg, J., & Nielsen, A. B. (2009) · Nutrition Reviews · doi:10.1111/j.1753-4887.1986.tb07607.x · Cited by 604
Fat Transport in Lipoproteins — An Integrated Approach to Mechanisms and Disorders
Fredrickson, D. S., Levy, R. I., & Lees, R. S. (1967) · New England Journal of Medicine · doi:10.1056/nejm196701192760305 · Cited by 526
VIGOROUS EXERCISE IN LEISURE-TIME AND THE INCIDENCE OF CORONARY HEART-DISEASE
Morris, J. N., Chave, S. P. W., Adam, C., Sirey, C., Epstein, L. H., & Sheehan, D. J. (1973) · The Lancet · doi:10.1016/s0140-6736(73)90128-1 · Cited by 456
Research works printed but not linked: 13
- Miller, 1973, J. Lab. clin. Med., 82, 876
- Goodman, 1973, J. Lipid Res., 52, 2646
- Insull, 1968, J. Lab. clin. Med., 72, 885
- Schreibman, 1973, Clin. Res., 21, 638
- P. Clifton-Bligh, N.E. Miller, P.J. Nestel, Clin. Sci. ((in the press)).
- Nikkilä, 1953, Scand. J. clin. Lab. Invest., 5
- Fredrickson, 1968, J. clin. Invest., 47, 2446, 10.1172/JCI105927 · DOI
- N.E. Miller, P.J. Nestel, Eur. J. clin. Invest. ((in the press)).
- Kannel, 1962, Geriatrics, 17, 675
- Murphy, 1962, J. Lab. clin. Med., 60, 86
- Kudchodkar, 1972, Clin. Res., 20, 944
- Jones, 1970, J. Lab. clin. Med., 75, 953
- Bondjers, 1974, Proc. Eur. Soc. clin. Invest., 8, 123
Cited by
Sorted by citations
Items 301–400 of 1,001
Shimada, M., Shimano, H., Gotoda, T., Yamamoto, K., Kawamura, M., Inaba, T., Yazaki, Y., & Yamada, N. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)46793-7 · Cited by 125
Brinton, E. A. (1996) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.16.3.431 · Cited by 125
Genetic aspects of arteriosclerosis.
Goldbourt, U., & Neufeld, H. N. (1986) · Arteriosclerosis An Official Journal of the American Heart Association Inc · doi:10.1161/01.atv.6.4.357 · Cited by 125
Avogaro, P., Bon, G. B., Cazzolato, G., & Rorai, E. (1980) · Atherosclerosis · doi:10.1016/0021-9150(80)90094-5 · Cited by 125
Kannel, W. B., & Schatzkin, A. G. (1984) · Progress in Cardiovascular Diseases · doi:10.1016/0033-0620(84)90008-2 · Cited by 124
Heterozygous familial hypercholesterolemia
Gagné, C., Moorjani, S., Brun, D., Toussaint, M., & Lupien, P. J. (1979) · Atherosclerosis · doi:10.1016/0021-9150(79)90101-1 · Cited by 124
Orchard, T. J., Donahue, R. P., Kuller, L. H., Hodge, P. N., & DRASH, A. L. (1983) · The Journal of Pediatrics · doi:10.1016/s0022-3476(83)80458-2 · Cited by 124
Relation between 25-hydroxyvitamin D3, apolipoprotein A-I, and high density lipoprotein cholesterol.
Auwerx, J. H., Bouillon, R., & Kesteloot, H. (1992) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.12.6.671 · Cited by 123
Impaired metabolism of high density lipoprotein in uremic patients
Shoji, T., Nishizawa, Y., Nishitani, H., Yamakawa, M., & Morii, H. (1992) · Kidney International · doi:10.1038/ki.1992.238 · Cited by 123
CHRISTENSEN, B. L., Glueck, C. J., Kwiterovich, P. O., deGroot, I., Chase, G. A., HEISS, G. M., Mowery, R. L., Tamir, I., & Rifkind, B. M. (1980) · Pediatric Research · doi:10.1203/00006450-198003000-00004 · Cited by 123
Miller, N. E., Weinstein, D. B., & Steinberg, D. H. (1977) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)41660-8 · Cited by 123
Self-citationChanges in insulin and lipid metabolism in males with asymptomatic hyperuricaemia
Zavaroni, I., Mazza, S., Fantuzzi, M., Dall’Aglio, E., Bonora, E., Delsignore, R., Passeri, M., & Reaven, G. M. (1993) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.1993.tb00700.x · Cited by 122
GENESTJR, J., Bard, J., Fruchart, J., Ordovás, J. M., WILSON, P., & Schaefer, E. J. (1991) · Atherosclerosis · doi:10.1016/0021-9150(91)90109-g · Cited by 122
Structure of the human hepatic triglyceride lipase gene
Cai, S. J., Wong, D. M., Chen, S. H., & Chan, L. (1989) · Biochemistry · doi:10.1021/bi00449a002 · Cited by 122
Mechanism of cholesterol efflux from cells
Phillips, M. C., McLean, L. R., Stoudt, G. W., & Rothblat, G. H. (1980) · Atherosclerosis · doi:10.1016/0021-9150(80)90220-8 · Cited by 122
Brinton, E. A., Oram, J. F., Chen, C. H., Albers, J. J., & Bierman, E. L. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)42497-5 · Cited by 121
Effects of Glucose and Insulin on Rat Apolipoprotein A-I Gene Expression
Murao, K., Wada, Y., Nakamura, T., Taylor, A. H., Mooradian, A. D., & Wong, N. C. W. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.30.18959 · Cited by 120
Impact of obesity on the risk of heart failure and survival after the onset of heart failure
Kenchaiah, S., Gaziano, J. M., & Vasan, R. S. (2004) · Medical Clinics of North America · doi:10.1016/j.mcna.2004.04.011 · Cited by 120
Wu, F. C. W., Farley, T. M. M., Peregoudov, A., & Waites, G. M. H. (1996) · Fertility and Sterility · doi:10.1016/s0015-0282(16)58166-7 · Cited by 120
Applebaum-Bowden, D. M., Haffner, S. M., WAHL, P. W., Hoover, J., Warnick, G. R., Albers, J. J., & Hazzard, W. R. (1985) · Arteriosclerosis An Official Journal of the American Heart Association Inc · doi:10.1161/01.atv.5.3.273 · Cited by 120
Kaprio, J., Ferrell, R. E., Kottke, B. A., Kamboh, M. I., & Sing, C. F. (1991) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.11.5.1330 · Cited by 119
High carbohydrate diets, triglyceride-rich lipoproteins, and coronary heart disease risk
Abbasi, F., McLaughlin, T., Lamendola, C. A., Kim, H. S., Tanaka, A., Wang, T., Nakajima, K., & Reaven, G. M. (2000) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)00604-9 · Cited by 119
Effects of amount and type of dietary fat on serum lipids, lipoproteins and apolipoproteins in man
Brussaard, J. H., Dallinga‐Thie, G. M., Groot, P. H. E., & Katan, M. (1980) · Atherosclerosis · doi:10.1016/0021-9150(80)90244-0 · Cited by 119
Lopes-Virella, M. F., Wohltmann, H. J., LOADHOLT, C. B., & Buse, M. G. (1981) · Diabetologia · doi:10.1007/bf00252657 · Cited by 119
Webb, O., Laskarzewski, P. M., & Glueck, C. J. (1984) · Metabolism · doi:10.1016/0026-0495(84)90222-1 · Cited by 118
Taggart, H. M., Applebaum-Bowden, D. M., Haffner, S. M., Warnick, G. R., Cheung, M. C., Albers, J. J., Chestnut, C. H., III, & Hazzard, W. R. (1982) · Metabolism · doi:10.1016/0026-0495(82)90166-4 · Cited by 118
Tahvanainen, E., Syvänne, M., Frick, M. H., Murtomäki-Repo, S., Antikainen, M., Kesäniemi, Y. A., Kauma, H., Pasternak, A., Taskinen, M., & Ehnholm, C. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1144 · Cited by 117
Desai, K., Bruckdorfer, K. R., Hutton, R. A., & Owen, J. S. (1989) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)38312-7 · Cited by 117
Belle, M. L., & Krauss, R. M. (1990) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)42342-9 · Cited by 117
Variation in paraoxonase-1 activity and atherosclerosis
Soran, H., Younis, N. N., Charlton-Menys, V., & Durrington, P. N. (2009) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e32832ec141 · Cited by 116
SERUM HIGH-DENSITY LIPOPROTEINS IN PERIPHERAL VASCULAR DISEASE
Bradby, G. V. H., Valente, A. J., & WALTON, K. W. (1978) · The Lancet · doi:10.1016/s0140-6736(78)92038-x · Cited by 116
Freedman, D. S., Shear, C. L., Srinivasan, S. R., Webber, L. S., & Berenson, G. S. (1985) · Preventive Medicine · doi:10.1016/0091-7435(85)90036-2 · Cited by 116
Miller, N. E., Weinstein, D. B., Carew, T. E., Koschinsky, T., & Steinberg, D. H. (1977) · Journal of Clinical Investigation · doi:10.1172/jci108772 · Cited by 116
Self-citationHigh density lipoprotein structure
Phillips, M. C. (2003) · Frontiers in bioscience · doi:10.2741/1077 · Cited by 115
Life-Style and Serum Lipids and Lipoproteins
Yoshiya, H. A. T. A., & Nakajima, K. (2000) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat1994.7.177 · Cited by 115
Reverse cholesterol transport: Physiology and pharmacology
Franceschini, G., MADERNA, P., & Sirtori, C. R. (1991) · Atherosclerosis · doi:10.1016/0021-9150(91)90073-c · Cited by 115
The Place of HDL in Cholesterol Management
Grundy, S. M. (1989) · Archives of Internal Medicine · doi:10.1001/archinte.149.3.505 · Cited by 115
Schaefer, J. R. (1999) · Atherosclerosis · doi:10.1016/s0021-9150(99)00053-2 · Cited by 114
Unexpected decrease in plasma high density lipoprotein cholesterol with weight loss
Thompson, P., Jeffery, R. W., Wing, R. R., & Wood, P. D. (1979) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/32.10.2016 · Cited by 114
Carlson, L. A. (1982) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1982.tb00938.x · Cited by 114
The paraoxonase gene family and coronary heart disease
Mackness, B., Durrington, P. N., & Mackness, M. (2002) · Current Opinion in Lipidology · doi:10.1097/00041433-200208000-00002 · Cited by 113
Determination of high-density lipoproteins: screening methods compared.
Kostner, G. M., Avogaro, P., Bon, G. B., Cazzolato, G., & Quinci, G. B. (1979) · Clinical Chemistry · doi:10.1093/clinchem/25.6.939 · Cited by 113
High-density and low-density lipoproteins and prevalence of vascular disease in diabetes mellitus.
Reckless, J. P. D., Betteridge, D. J., Wu, P.-P., Payne, B., & Galton, D. J. (1978) · BMJ · doi:10.1136/bmj.1.6117.883 · Cited by 113
Pathogenic roles of post-heparin lipases in lipid abnormalities in hemodialysis patients
Chan, M. K., Persaud, J. W., Varghese, Z., & Moorhead, J. F. (1984) · Kidney International · doi:10.1038/ki.1984.94 · Cited by 113
Kameda, K., MATSUZAWA, Y., KUBO, M., Ishikawa, K., Maejima, I., Yamamura, T., Yamamoto, A. C., & Tarui, S. (1984) · Atherosclerosis · doi:10.1016/0021-9150(84)90171-0 · Cited by 113
Tsujita, Y., Kuroda, M., Tanzawa, K., KITANO, N., & Endo, A. (1979) · Atherosclerosis · doi:10.1016/0021-9150(79)90174-6 · Cited by 112
Study on Antihypertensive and Antihyperlipidemic Effects of Marine Algae
Ren, D., Noda, H., Amano, H., Nishino, T., & Nishizawa, K. (1994) · Fisheries Science · doi:10.2331/fishsci.60.83 · Cited by 111
Shoji, T., Nishizawà, Y., Kawagishi, T., Tanaka, M., Kawasaki, K., Tabata, T., Inoue, T., & Morii, H. (1997) · Atherosclerosis · doi:10.1016/s0021-9150(97)00054-3 · Cited by 111
Voyiaziakis, E., Goldberg, I. J., Plump, A. S., Rubin, E. M., Breslow, J. L., & Huang, L. (1998) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)33893-1 · Cited by 111
Raaij, J. M. A. V., Katan, M., HAUTVAST, J. G. A. J., & Hermus, R. J. J. (1981) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/34.7.1261 · Cited by 111
ALPHA LIPOPROTEIN (HDL) CHOLESTEROL IN THE SERUM AND THE RISK OF CORONARY HEART DISEASE AND DEATH
Keys, A. B. (1980) · The Lancet · doi:10.1016/s0140-6736(80)90280-9 · Cited by 111
Franceschini, G., Sirtori, M., Vaccarino, V., Gianfranceschi, G., Rezzonico, L. F., Chiesa, G., & Sirtori, C. R. (1989) · Arteriosclerosis An Official Journal of the American Heart Association Inc · doi:10.1161/01.atv.9.4.462 · Cited by 111
Future Therapeutic Directions in Reverse Cholesterol Transport
Khera, A. V., & Rader, D. J. (2010) · Current Atherosclerosis Reports · doi:10.1007/s11883-009-0080-0 · Cited by 111
Reaven, G. M., Segal, K. R., Hauptman, J. B., Boldrin, M. N., & Lucas, C. P. (2001) · The American Journal of Cardiology · doi:10.1016/s0002-9149(00)01521-6 · Cited by 110
The Changing Face of HDL and the Best Way to Measure It
Karathanasis, S. K., Freeman, L. A., Gordon, S. M., & Remaley, A. T. (2016) · Clinical Chemistry · doi:10.1373/clinchem.2016.257725 · Cited by 112
Dyslipidemias in the Prevention of Cardiovascular Disease: Risks and Causality
Graham, I. M., Cooney, M. T., Bradley, D., Dudina, A. L., & Reiner, Ž. (2012) · Current Cardiology Reports · doi:10.1007/s11886-012-0313-7 · Cited by 113
Asztalos, B. F., Horvath, K. V., McNamara, J. R., Roheim, P. S., Rubinstein, J. J., & Schaefer, E. J. (2002) · Atherosclerosis · doi:10.1016/s0021-9150(02)00149-1 · Cited by 109
The Role of Lipids and Lipoproteins in Atherosclerosis
Linton, M. F., Yancey, P. G., Davies, S. S., Jerome, W. G., Linton, E. F., Song, W., Doran, A. C., & Vickers, K. C. (2015) · Europe PMC (PubMed Central) · Cited by 108
Insulin Resistance: the Link Between Obesity and Cardiovascular Disease
Reaven, G. M. (2008) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2008.06.005 · Cited by 111
Sorci‐Thomas, M. G., Prack, M. M., Dashti, N., Johnson, F., Rudel, L. L., & Williams, D. L. (1989) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)38254-7 · Cited by 108
Correlation without a cause: an epidemiological odyssey
Smith, G. D., & Phillips, A. N. (2020) · International Journal of Epidemiology · doi:10.1093/ije/dyaa016 · Cited by 109
Nishiwaki, M., Ishikawa, T., Ito, T., Shige, H., Tomiyasu, K., Nakajima, K., Kondo, K. N., Hashimoto, H., Saitoh, K., Manabe, M., et al. (1994) · Atherosclerosis · doi:10.1016/0021-9150(94)90195-3 · Cited by 107
In vitro and in vivo evidence for the role of HDL in reverse cholesterol transport
Pieters, M. N., Schouten, D., & van Berkel, T. J. C. (1994) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/0925-4439(94)90069-8 · Cited by 107
Barter, P. J., & Lally, J. I. (1979) · Metabolism · doi:10.1016/0026-0495(79)90068-4 · Cited by 107
Williams, P. T., Stefanick, M. L., Vranizan, K. M., & Wood, P. D. (1994) · Metabolism · doi:10.1016/0026-0495(94)90277-1 · Cited by 106
The evidence for the antiatherogenicity of high density lipoprotein in man
Miller, N. E. (1978) · Lipids · doi:10.1007/bf02533850 · Cited by 106
Self-citationKoren, E., Puchois, P., Alaupovic, P., Fesmire, J. D., Kandoussi, A., & Fruchart, J. (1987) · Clinical Chemistry · doi:10.1093/clinchem/33.1.38 · Cited by 106
Alcohol consumption and its relation to cardiovascular risk factors in British women.
Razay, G., Heaton, K. W., Bolton, C., & Hughes, A. (1992) · BMJ · doi:10.1136/bmj.304.6819.80 · Cited by 105
Sites and mechanisms of uptake and degradation of high density and low density lipoproteins
Pittman, R. C., & Steinberg, D. H. (1984) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)34435-7 · Cited by 105
Couture, P., Otvos, J. D., Cupples, L. A., Wilson, P. W. F., Schaefer, E. J., & Ordovás, J. M. (1999) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)34905-1 · Cited by 106
Biochemical and Haematological Response to Alcohol Intake
Shaper, A. G., Pocock, S., Ashby, D., Walker, M., & Whitehead, T. P. (1985) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1177/000456328502200104 · Cited by 105
Prevention of low density lipoprotein aggregation by high density lipoprotein or apolipoprotein A-I.
Khoo, J., Miller, E. R., McLoughlin, P., & Steinberg, D. H. (1990) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)42832-9 · Cited by 104
Schultz, J. R., Gong, E. L., McCall, M. R., Nichols, A. V., Clift, S., & Rubin, E. M. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)36658-x · Cited by 104
High-Density Lipoprotein Metabolism
Nicoll, A. D., Miller, N. E., & Lewis, B. (1980) · Advances in lipid research · doi:10.1016/b978-0-12-024917-6.50008-2 · Cited by 104
Self-citationWynn, V., & Niththyananthan, R. (1982) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(16)32486-3 · Cited by 104
Pomerantz, K. B., & Hajjar, D. P. (1989) · Arteriosclerosis An Official Journal of the American Heart Association Inc · doi:10.1161/01.atv.9.4.413 · Cited by 104
Knopp, R. H., Bergelin, R. O., WAHL, P. W., Walden, C. E., Chapman, M., & Irvine, S. (1982) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(82)90107-7 · Cited by 103
Hopkins, G. J., & Barter, P. J. (1990) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)38740-x · Cited by 103
Lipid metabolism in diabetes mellitus
Saudek, C. D., & Eder, H. A. (1979) · The American Journal of Medicine · doi:10.1016/0002-9343(79)91126-4 · Cited by 103
Importance of Identifying the Overweight Patient Who Will Benefit the Most by Losing Weight
Reaven, G. M. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-138-5-200303040-00012 · Cited by 104
Stalder, M., Pometta, D., & Suenram, A. (1981) · Diabetologia · doi:10.1007/bf00281546 · Cited by 102
Yamashita, S., Hui, D. Y., Wetterau, J. R., Sprecher, D. L., Harmony, J. A. K., Sakai, N., Matsuzawa, Y., & Tarui, S. (1991) · Metabolism · doi:10.1016/0026-0495(91)90097-g · Cited by 102
Couture, P., Otvos, J. D., Cupples, L. A., Lahoz, C., Wilson, P. W. F., Schaefer, E. J., & Ordovás, J. M. (2000) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.20.3.815 · Cited by 102
Role of low-density lipoproteins in atherogenesis and development of coronary heart disease
Grundy, S. M. (1995) · Clinical Chemistry · doi:10.1093/clinchem/41.1.139 · Cited by 101
Probucol as an antioxidant and antiatherogenic drug
Kuzuya, M., & Kuzuya, F. (1993) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(93)90510-2 · Cited by 101
Effect of Green Tea By-product on Performance and Body Composition in Broiler Chicks
Yang, C., Yang, I., Oh, D. H., Bae, I. H., Cho, S. G., Kong, I. G., Uuganbayar, D., Nou, I., & Choi, K. S. (2003) · Asian-Australasian Journal of Animal Sciences · doi:10.5713/ajas.2003.867 · Cited by 101
Changes in plasma lipoproteins during low-fat, high-carbohydrate diets: effects of energy intake
Kasim-Karakas, S. E., Almario, R. U., Mueller, W. M., & Peerson, J. M. (2000) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/71.6.1439 · Cited by 101
Sakai, N., Matsuzawa, Y., Hirano, K., Yamashita, S., Nozaki, S., Ueyama, Y., Kubo, M., & Tarui, S. (1991) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.11.1.71 · Cited by 101
Yang, X. P., Yan, D., Qiao, C., Liu, R. J., Chen, J.-G., Li, J., Schneider, M., Lagrost, L., Xiao, X., & Jiang, X.-C. (2003) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000085841.55248.13 · Cited by 103
Doolittle, M. H., LeBoeuf, R. C., Warden, C. H., Bee, L. M., & Lusis, A. J. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)46234-x · Cited by 101
Familial apolipoprotein A-I and C-III deficiency, variant II.
Schaefer, E. J., Ordovás, J. M., Law, S. W. T., Ghiselli, G., Kashyap, M. L., Srivastava, L., Heaton, W. H., Albers, J. J., CONNOR, W. E., & Lindgren, F. T. (1985) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)34282-6 · Cited by 99
Insulin Resistance, Type 2 Diabetes Mellitus, and Cardiovascular Disease: The End of the Beginning
Reaven, G. (2005) · Circulation · doi:10.1161/circulationaha.105.504670 · Cited by 98
Anti-Inflammatory Properties of Paraoxonase-1 in Atherosclerosis
Mackness, B., & Mackness, M. (2009) · Advances in experimental medicine and biology · doi:10.1007/978-1-60761-350-3_13 · Cited by 98
Zoratti, R. (1998) · European Journal of Epidemiology · doi:10.1023/a:1007492202045 · Cited by 98
Parodi, P. W. (2009) · International Dairy Journal · doi:10.1016/j.idairyj.2009.01.001 · Cited by 99
Impact of age on the metabolism of VLDL, IDL, and LDL apolipoprotein B-100 in men.
Millar, J. S., Lichtenstein, A. H., Cuchel, M., Dolnikowski, G. G., Hachey, D. L., Cohn, J. S., & Schaefer, E. J. (1995) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)41124-1 · Cited by 98
Evaluation of a new HDL2/HDL3 quantitation method based on precipitation with polyethylene glycol
Kostner, G. M., Molinari, E., & Pichier, P. (1985) · Clinica Chimica Acta · doi:10.1016/0009-8981(85)90224-4 · Cited by 98
Schernthaner, G.-H., Kostner, G. M., Dieplinger, H., Prager, R., & Mühlhauser, I. (1983) · Atherosclerosis · doi:10.1016/0021-9150(83)90139-9 · Cited by 98
Williams, P. T., Krauss, R. M., VRANIZAN, K. M., Stefanick, M. L., Wood, P. D., & Lindgren, F. T. (1992) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.12.3.332 · Cited by 97
A splice-junction mutation responsible for familial apolipoprotein A-II deficiency.
Deeb, S. S., Takata, K., Peng, R., Kajiyama, G., & Albers, J. J. (1990) · PubMed · Cited by 97
Metadata
- Authors
- Miller, G. J., & Miller, N. E.
- Affiliations
- University Hospital Llandough (GB)
- Edinburgh Royal Infirmary (GB)
- ORCID
- Miller, G.J
- Venue
- The Lancet
- Publisher
- Elsevier BV
- Published
- 1975-01
- Volume
- 305
- Issue
- 7897
- Pages
- 16-19
- ISSN
- 0099-5355 (ISSN-L)
- 0140-6736
- OpenAlex
- W1994967652
- Cited by
- 2,621
- References
- 59
- Citations by year
- 2026: 5 · 2025: 11 · 2024: 9 · 2023: 7 · 2022: 15 · 2021: 17 · 2020: 24 · 2019: 18 · 2018: 18 · 2017: 17 · 2016: 29 · 2015: 29 · 2014: 22 · 2013: 32 · 2012: 26
- FWCI
- 157.87
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Lancet (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Paraoxonase enzyme and polymorphisms
- Keywords
- high-density lipoprotein, ischemic heart disease, atherosclerosis, cholesterol metabolism, hypercholesterolemia, hypertriglyceridemia, obesity, diabetes mellitus, sex differences, cardiovascular risk factors
- MeSH terms
- Arteries, Arteriosclerosis, Cholesterol, Coronary Disease, Denmark, Inuit, Female, Finland, Humans, Lipoproteins, HDL, Lipoproteins, LDL, Lipoproteins, VLDL, Liver, Male, Middle Aged, Sex Factors, Sweden, Triglycerides, United States
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review